528 main street, inc.

p.o. box 43
fleischmanns, new york 12430

NYS Entity Status
ACTIVE

NYS Filing Date
JULY 22, 2014

NYS DOS ID#
4610036

County
DELAWARE

Jurisdiction
NEW YORK

Registered Agent
NONE

NYS Entity Type
DOMESTIC BUSINESS CORPORATION

Name History
2014 - 528 MAIN STREET, INC.









Buffer

submit to reddit

Telephone
n/a

Fax
n/a

Website
n/a

Email address
n/a

LinkedIn
n/a

Facebook
n/a

Google+
n/a

Twitter
n/a

Pinterest
n/a

Instagram
n/a



  • Around the Web

  • MTV Mines the Past for Its Future: ‘Total Request Live’
    By JOHN KOBLIN - Sunday Jul 30, 2017

    Remember the “TRL” studio and crowds in Times Square? Music? Carson Daly? MTV hopes you do, and will tune in again.

    Source: NYT > Home Page
  • Coach Inc. is changing its name, and shoppers are pissed
    By Reuters - Wednesday Oct 11, 2017

    Coach Inc will change its corporate name to Tapestry Inc, it said on Wednesday, as it creates a broader umbrella for its high-end brands without diluting the iconic name known mainly for selling luxury handbags. The company’s shares were down 2 percent in early trading following the announcement in which Tapestry will be the holding...

    Source: New York Post: Business
  • A Main Street Independence Day
    Sunday Jul 2, 2017

    Veterans, antique cars, volleyball players—and flags everywhere.

    Source: The Wall Street Journal: Opinion
  • Japan Inc. Under Pressure
    Tuesday Oct 17, 2017

    The Kobe Steel scandal may be a sign of corporate progress.

    Source: The Wall Street Journal: Opinion
  • For Time Inc.'s Magazines, Fewer Copies Is the Way Forward
    Tuesday Oct 10, 2017

    The publisher is cutting back on the circulation and frequency of some of its biggest titles, part of a far-reaching cost-reduction and restructuring program meant to ensure the profitability of its core brands.

    Source: The Wall Street Journal: U.S. Business
  • Stealthy NY Startup Rocket Pharma Merges With Inotek, Heads to Nasdaq
    By Ben Fidler - Tuesday Sep 12, 2017

    Rocket Pharmaceuticals, a stealthy gene therapy startup in New York City, has made its first splash. Through a merger with struggling Inotek Pharmaceuticals (NASDAQ: ITEK), Rocket, a company developing treatments for a variety of rare blood diseases, has taken itself public. Rocket shareholders are expected to own 81 percent of the combined company, with Inotek […]

    Source: Xconomy New York